Agata Bannink-Gawryszuk

Dr. Agata Bannink-Gawryszuk

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Radiotherapy and Oncology
Verified
Journal Article
Open access
PDF file
AHArno C. Hessels
Arno C. Hessels
HLHans Langendijk
Hans Langendijk
ABAgata Bannink-Gawryszuk
Agata Bannink-Gawryszuk
MHMart A.A.M. Heersters
Mart A.A.M. Heersters
NSNathalie L.M. van der Salm
Nathalie L.M. van der Salm
JMJohn H. Maduro
John H. Maduro
• Normal tissue radiation tolerance in children is different from adults. • In the abdomen, the pancreas and spleen are the most radiosensitive organs-at-risk. • The gonads should be considered the most radiosensitive pelvic organs in children. • Without quantifiable dose effect data, strive for ‘as low as reasonably achievable’.

29 September 2025 in Radiotherapy and Oncology
Verified
Journal Article
Open access
SVS.P.M. de Vette
S.P.M. de Vette
HNH. Neh
H. Neh
LHL. van der Hoek
L. van der Hoek
DMD.C. MacRae
D.C. MacRae
HCHung Chu
Hung Chu
LDL.V. van Dijk
L.V. van Dijk
Late radiation-associated dysphagia after head and neck cancer (HNC) significantly impacts patient's health and quality of life. Conventional normal tissue complication probability (NTCP) models use discrete dose parameters to predict toxicity risk but fail to fully capture the complexity of this side effect. Deep learning (DL) offers potential improvements by incorporating 3D dose data for all anatomical structures involved in swallowing. This study aims to enhance dysphagia prediction with 3D DL NTCP models compared to conventional NTCP models. A multi-institutional cohort of 1484 HNC patients was used to train and validate a 3D DL model (Residual Network) incorporating 3D dose distributions, organ-at-risk segmentations, and CT scans, with or without patient- or treatment-related data. Predictions of grade ≥ 2 dysphagia (CTCAEv4) at six months post-treatment were evaluated using area under the curve (AUC) and calibration curves. Results were compared to a conventional NTCP model based on pre-treatment dysphagia, tumour location, and mean dose to swallowing organs. Attention maps highlighting regions of interest for individual patients were assessed. DL models outperformed the conventional NTCP model in both the independent test set (AUC = 0.80-0.84 versus 0.76) and external test set (AUC = 0.73-0.74 versus 0.63) in AUC and calibration. Attention maps showed a focus on the oral cavity and superior pharyngeal constrictor muscle. DL NTCP models performed significantly better than the conventional NTCP model, suggesting the benefit of using 3D-input over the conventional discrete dose parameters. Attention maps highlighted relevant regions linked to dysphagia, supporting the utility of DL for improved predictions.

26 June 2024 in Radiotherapy and Oncology
Verified
Journal Article
Open access
LTLaura Toussaint
Laura Toussaint
WMWitold Matysiak
Witold Matysiak
CAClaire Alapetite
Claire Alapetite
JAJavier Aristu
Javier Aristu
ABAgata Bannink-Gawryszuk
Agata Bannink-Gawryszuk
YLYasmin Lassen-Ramshad
Yasmin Lassen-Ramshad
As no guidelines for pencil beam scanning (PBS) proton therapy (PT) of paediatric posterior fossa (PF) tumours exist to date, this study investigated planning techniques across European PT centres, with special considerations for brainstem and spinal cord sparing. A survey and a treatment planning comparison were initiated across nineteen European PBS-PT centres treating paediatric patients. The survey assessed all aspects of the treatment chain, including but not limited to delineations, dose constraints and treatment planning. Each centre planned two PF tumour cases for focal irradiation, according to their own clinical practice but based on common delineations. The prescription dose was 54 Gy(RBE) for Case 1 and 59.4 Gy(RBE) for Case 2. For both cases, planning strategies and relevant dose metrics were compared. Seventeen (89 %) centres answered the survey, and sixteen (80 %) participated in the treatment planning comparison. In the survey, thirteen (68 %) centres reported using the European Particle Therapy Network definition for brainstem delineation. In the treatment planning study, while most centres used three beam directions, their configurations varied widely across centres. Large variations were also seen in brainstem doses, with a brainstem near maximum dose (D2%) ranging from 52.7 Gy(RBE) to 55.7 Gy(RBE) (Case 1), and from 56.8 Gy(RBE) to 60.9 Gy(RBE) (Case 2). This study assessed the European PBS-PT planning of paediatric PF tumours. Agreement was achieved in e.g. delineation-practice, while wider variations were observed in planning approach and consequently dose to organs at risk. Collaboration between centres is still ongoing, striving towards common guidelines.

22 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
WMWitold Matysiak
Witold Matysiak
MLMarieke C. Landeweerd
Marieke C. Landeweerd
ABAgata Bannink-Gawryszuk
Agata Bannink-Gawryszuk
HWHiska L. van der Weide
Hiska L. van der Weide
CBCharlotte L Brouwer
Charlotte L Brouwer
JMJohn H. Maduro
John H. Maduro
Proton therapy is a promising modality for craniospinal irradiation (CSI), offering dosimetric advantages over conventional treatments. While significant attention has been paid to spine fields, for the brain fields, only dose reduction to the lens of the eye has been reported. Hence, the objective of this study is to assess the potential gains and feasibility of adopting different treatment planning techniques for the entire brain within the CSI target. To this end, eight previously treated CSI patients underwent retrospective replanning using various techniques: (1) intensity modulated proton therapy (IMPT) optimization, (2) the modification/addition of field directions, and (3) the pre-optimization removal of superficially placed spots. The target coverage robustness was evaluated and dose comparisons for lenses, cochleae, and scalp were conducted, considering potential biological dose increases. The target coverage robustness was maintained across all plans, with minor reductions when superficial spot removal was utilized. Single- and multifield optimization showed comparable target coverage robustness and organ-at-risk sparing. A significant scalp sparing was achieved in adults but only limited in pediatric cases. Superficial spot removal contributed to scalp V30 Gy reduction at the expense of lower coverage robustness in specific cases. Lens sparing benefits from multiple field directions, while cochlear sparing remains impractical. Based on the results, all investigated plan types are deemed clinically adoptable.

17 November 2024 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
PLPeter Lægdsmand
Peter Lægdsmand
WMWitold Matysiak
Witold Matysiak
LMLudvig P. Muren
Ludvig P. Muren
YLYasmin Lassen-Ramshad
Yasmin Lassen-Ramshad
JMJohn H. Maduro
John H. Maduro
LTLaura Toussaint
Laura Toussaint
Background and Purpose: Radiotherapy for paediatric posterior fossa tumours may cause complications in the brainstem and upper spinal cord due to high doses. With proton therapy (PT) this risk may increase due to higher relative biological effectiveness (RBE) from elevated linear energy transfer (LET). This study assesses variations in LET in the brainstem and spinal cord in proton treatment plans from European centres. Materials and Methods: Ten European PT centres using spot-scanning PT planned two paediatric posterior fossa cases: One overlapping partly with the brainstem and upper spinal cord, prescribed 54 Gy(RBE), and the second wrapping around these organs, prescribed 59.4 Gy(RBE). Dose-averaged LET distributions were assessed in volumes of the brainstem and spinal cord irradiated to over 50 Gy(RBE = 1.1). The maximum hinge angle effect on near-maximum RBE-weighted doses using the Unkelbach RBE model was also investigated. Results: In the first case, the mean LET in brainstem volumes receiving more than 50 Gy(RBE = 1.1) ranged from 2.8 keV/mu m to 3.6 keV/mu m across centres (median: 3.3 keV/mu m). In the second case, treatment plans showed a narrower range of mean LET in the brainstem, from 2.5 keV/mu m to 2.8 keV/mu m (median: 2.7 keV/mu m). There was no statistically significant impact of the maximum hinge angle. Conclusions: LET distributions vary across centres due to different techniques but are also influenced significantly by factors like shape and position of the target volume.

21 December 2024 in Radiotherapy and Oncology
Verified
Journal Article
Open access
HLHans Paul van der Laan
Hans Paul van der Laan
ABAgata Bannink-Gawryszuk
Agata Bannink-Gawryszuk
ASArjen van der Schaaf
Arjen van der Schaaf
HLHans Langendijk
Hans Langendijk
To assess the feasibility and benefit of NTCP optimized aspiration-prevention treatment planning by sparing specific aspiration related organs at risk, and to assess the impact of baseline complaints on the planning results. This in silico planning study included 30 HNC patients who were previously treated with definitive radiotherapy. New fully automated plans, allowing for sparing specific aspiration related organs at risk, were optimised directly on normal tissue complication probability (NTCP) models for common toxicities: xerostomia and dysphagia. Optimisation was performed with and without aspiration-prevention, i.e., with and without specific sparing of recently identified aspiration-related muscles, and with and without the assumption of existing baseline complaints. All plans complied with the pre-defined treatment planning quality criteria and were successful in limiting the risk of xerostomia and dysphagia. Aspiration-prevention VMAT, optimized using the additional NTCP model for aspiration, significantly reduced the estimated risk of late aspiration (p < 0.001) in all 30 patients when compared to plans without NTCP optimisation for late aspiration. The predicted risk of late aspiration was reduced even further when baseline aspiration was assumed present during optimisation, resulting in an average risk reduction of 13.3 % versus 8.3 % in plans assuming no aspiration at baseline. Aspiration-prevention did not reduce overall plan quality and maintained NTCP values obtained for various other toxicities. Sparing specific aspiration-related organs at risk has the potential to significantly reduce the risk of late RT-induced aspiration, especially in patients who experience aspiration already at baseline.